Edmonds Duncan Registered Investment Advisors, LLC - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Edmonds Duncan Registered Investment Advisors, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$12,000
-42.9%
41,0000.0%0.00%
-33.3%
Q4 2021$21,000
-22.2%
41,000
+57.7%
0.01%
-25.0%
Q3 2021$27,000
-52.6%
26,000
-36.6%
0.01%
-55.6%
Q2 2021$57,000
-18.6%
41,0000.0%0.02%
-21.7%
Q1 2021$70,000
-21.3%
41,0000.0%0.02%
-23.3%
Q4 2020$89,000
-12.7%
41,000
-43.1%
0.03%
+42.9%
Q3 2020$102,000
+64.5%
72,000
+38.5%
0.02%
+61.5%
Q2 2020$62,00052,0000.01%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders